Cargando…

Impact of Apo E gene polymorphism on HCV therapy related outcome in a cohort of HCV Egyptian patients

The functional apolipoprotein E (Apo E) gene polymorphism could be used as a determinant of outcome of HCV infection. This study aimed to demonstrate the impact of Apo E genotype on the response to HCV combined therapy. Material and methods: The study has been implemented on 125 individuals with per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomaa, Howayda E., Mahmoud, Mohamed, Saad, Nevine E., Saad-Hussein, Amal, Ismail, Somaia, Thabet, Eman H., Farouk, Hebatallah, Kandil, Dina, Heiba, Ahmed, Hafez, Wael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Scientific Research and Technology, Egypt 2018
Materias:	Medical Biotechnology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296613/ https://www.ncbi.nlm.nih.gov/pubmed/30647703 http://dx.doi.org/10.1016/j.jgeb.2017.10.008

Ejemplares similares

Interactive Effects of Immunoglobulin Gamma and Human Leucocyte Antigen Genotypes on Response to Interferon Based Therapy of Hepatitis C Virus
por: Gomaa, Howayda E., et al.
Publicado: (2015)

Association of TNF-α –308G/A, SP-B 1580 C/T, IL-13 –1055 C/T gene polymorphisms and latent adenoviral infection with chronic obstructive pulmonary disease in an Egyptian population
por: Ezzeldin, Nada, et al.
Publicado: (2012)

Association of HCV with diabetes mellitus: an Egyptian case-control study
por: Elhawary, Eman I, et al.
Publicado: (2011)

Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir
por: Nada, Ali, et al.
Publicado: (2020)

The Role of ApoE in HCV Infection and Comorbidity
por: Gong, Yue, et al.
Publicado: (2019)

Peroxisome proliferator-activated receptor-γ polymorphism (rs1801282) is associated with obesity in Egyptian patients with coronary artery disease and type 2 diabetes mellitus
por: Hasan, Nehal Salah, et al.
Publicado: (2017)

Altered Protein and Gene Expression of Beclin-1 Correlates with Poor Prognosis of Hcv-Associated Hepatocellular Carcinoma in Egyptian Patients
por: Ehsan, Nermine Ahmed, et al.
Publicado: (2021)

TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis
por: Nomair, Azhar Mohamed, et al.
Publicado: (2021)

Significance of growth differentiation factor 15 in chronic HCV patients
por: Halim, Mohab H., et al.
Publicado: (2017)

TH1 cytokine response to HCV peptides in Egyptian health care workers: a pilot study
por: Rafik, Mona M, et al.
Publicado: (2013)

The impact of Middle Eastern Origin, HIV, HCV, and HIV/HCV co‐infection in the development of hypovitaminosis D in adults
por: Warraich, Saad, et al.
Publicado: (2018)

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
por: Tabll, Ashraf, et al.
Publicado: (2011)

Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients
por: Hassan, Marwa, et al.
Publicado: (2022)

Sexual Transmission of HCV in Heterologous Monogamous Spouses
por: Rafik, Mona M., et al.
Publicado: (2014)

Occult HCV infection in liver transplanted patients: frequency and consequences
por: Saad, Zeinab M, et al.
Publicado: (2022)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Acute Hepatitis Caused by Genotype 4 HCV Presenting with Microangiopathic Hemolytic Anemia
por: Kamal, Ahmed, et al.
Publicado: (2018)

Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities
por: El-Sokkary, Rehab H, et al.
Publicado: (2017)

Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients
por: W. ABD EL-WAHAB, Ekram, et al.
Publicado: (2014)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

Dual versus triple therapy in treatment of hepatitis C virus (HCV)
por: Bishai, Nevine, et al.
Publicado: (2022)

Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis
por: Abdel-Hafiz, Samah Mamdouh, et al.
Publicado: (2018)

MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients
por: El-Ahwany, Eman G. E., et al.
Publicado: (2019)

A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients
por: Omran, Moataza H, et al.
Publicado: (2013)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value
por: Shehab-Eldeen, Somaia, et al.
Publicado: (2023)

Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease
por: Salama, Hosny, et al.
Publicado: (2014)

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection
por: Wang, Yuhan, et al.
Publicado: (2021)

Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4
por: Rizk, Hanan H., et al.
Publicado: (2016)

Assessment of immunological changes in Epstein-Barr virus co-infection in Egyptian chronic HCV patients
por: Shoman, Sahar, et al.
Publicado: (2014)

HCV and HEV: two players in an Egyptian village, a study of prevalence, incidence, and co-infection
por: Elhendawy, Mohammed, et al.
Publicado: (2020)

Impact of IL-10 (−1082) Promoter–Single Nucleotide Polymorphism on the Outcome of Hepatitis C Virus Genotype 4 Infection
por: Helal, Soheir F., et al.
Publicado: (2014)

HCV resistance
por: Halfon, Philippe
Publicado: (2012)

HCV and Lymphoproliferation
por: Zignego, Anna Linda, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dgifeg2p9p2cv55olsr3oqfhgl